Oral Communication on Haemophilia

Thursday 23 October

Abstract titles & Authors

Moderators: Henri Spronk, Caterina Casari

14.30
14.45

OC11-OP01 – IMMUNOGLOBULIN PROFILE DURING THE DEVELOPMENT AND SUCCESSFUL TREATMENT OF A LOW-TITRE INHIBITOR WITH ASSOCIATED COMPLEMENTACTIVATION-RELATED PSEUDOALLERGY (CARPA) IN A CHILD WITH SEVERE HEMOPHILIA B. – Arnaud Bonnefoy, CHU Sainte-Justine

14.45
15.00

OC11-OP02 – THE IMPACT OF PHARMACOKINETIC-GUIDED PROPHYLAXIS WITH AN EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII ON CLINICAL OUTCOMES IN HEMOPHILIA A PATIENTS: A TAIWANESE MULTICENTER STUDY – Jen-Yin Hou, MacKay Children’s Hospital

15.00
15.15

OC11-OP03 – MONITORING AND OUTCOMES OF MAJOR SURGERY IN PATIENTS WITH HEMOPHILIA A TREATED WITH EMICIZUMAB – A CASE REPORT SERIES – Adrian Kimiaei, Karolinska University Hospital

15.15
15.30

OC11-OP04 – INTRINSIC ACTIVATION OF THROMBIN GENERATION IS A PROMISING TOOL TO MONITOR SEVERE HEMOPHILIA A PATIENTS ON EMICIZUMAB – Emma Urlings, Maastricht University Medical Center